Hamill Matthew M, Pettifor John M, Ward Kate A, Norris Shane A, Prentice Ann
Medical Research Council Elsie Widdowson Laboratory Cambridge UK.
South African Medical Research Council/University of Witwatersrand Developmental Pathways for Health Research Unit, Faculty of Health Sciences University of Witwatersrand Johannesburg South Africa.
JBMR Plus. 2020 Mar 18;4(5):e10343. doi: 10.1002/jbm4.10343. eCollection 2020 May.
Human immunodeficiency virus- (HIV-) infection and antiretroviral therapy (ART) exposure are associated with bone loss. African data are limited despite the region's HIV burden. Of 247 ART-naïve, premenopausal, urban, black African women aged 33.9 ± 6.6 years from Soweto, South Africa, measured at baseline, 110 underwent anthropometry, DXA, and blood and urine collections at 12 and 24 months; 39 were HIV-negative (Nref), 28 were people with HIV (PWH) not ART-exposed for the duration of the study (ART-N), and 43 were PWH who were ART-exposed within the first 12 months (ART-Y). At baseline, the ART-Y group had lower BMI and fat mass than the Nref group. Within 12 months of ART initiation, areal bone mineral density (aBMD) had decreased at the lumbar spine and at the whole body less head, despite increased weight, and hip aBMD had not increased in line with the Nref group. There was no evidence of further bone changes between 12 and 24 months. By 24 months, the ART-Y women had gained weight and fat mass, but remained lighter with less fat than the Nref women. ART initiation normalized the low serum albumin of the ART-Y group at baseline, but was associated with elevated bone turnover markers at 12 and 24 months. Vitamin D status and renal phosphate handling were normal. ART-N had similar aBMD and other characteristics to the Nref group throughout, except unlike the Nref group, weight and fat mass did not increase and serum albumin decreased. This study in African women of childbearing age demonstrated that the bone loss that had occurred in these PWH after ART initiation did not continue after 12 months and that bone loss did not occur in ART-unexposed PWH over 2 years. At 24 months, despite gains in weight and fat mass, ART-exposed women remained lighter, with lower aBMD, fat mass, and higher bone turnover than women without HIV. More studies are required to establish if the bone loss and fat gain reverse, stabilize, or continue with further ART exposure, particularly during and after menopause. © 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
人类免疫缺陷病毒(HIV)感染和抗逆转录病毒疗法(ART)暴露与骨质流失有关。尽管非洲地区的HIV负担较重,但该地区的数据有限。在南非索韦托,对247名年龄为33.9±6.6岁、基线时未经ART治疗的绝经前城市非洲黑人女性进行了测量,其中110人在12个月和24个月时接受了人体测量、双能X线吸收法(DXA)以及血液和尿液采集;39人为HIV阴性(Nref),28人为在研究期间未接受ART治疗的HIV感染者(PWH)(ART-N),43人为在最初12个月内接受ART治疗的PWH(ART-Y)。基线时,ART-Y组的体重指数(BMI)和脂肪量低于Nref组。在开始ART治疗的12个月内,尽管体重增加,但腰椎和全身(不包括头部)的骨矿物质密度(aBMD)仍有所下降,且髋部aBMD未像Nref组那样增加。在12个月至24个月之间没有进一步骨变化的证据。到24个月时,ART-Y组的女性体重和脂肪量有所增加,但仍比Nref组女性体重更轻、脂肪更少。开始ART治疗使ART-Y组基线时较低的血清白蛋白恢复正常,但在12个月和24个月时与骨转换标志物升高有关。维生素D状态和肾脏磷酸盐处理正常。ART-N组在整个过程中的aBMD和其他特征与Nref组相似,只是与Nref组不同的是,其体重和脂肪量没有增加,血清白蛋白下降。这项针对非洲育龄女性的研究表明,这些接受ART治疗的PWH在开始ART治疗后发生的骨质流失在12个月后没有继续,且未接受ART治疗超过2年的PWH没有发生骨质流失。到24个月时,尽管体重和脂肪量有所增加,但接受ART治疗的女性仍比未感染HIV的女性体重更轻,aBMD、脂肪量更低,骨转换更高。需要更多研究来确定骨质流失和脂肪增加是否会随着进一步的ART暴露而逆转、稳定或继续,特别是在绝经期间和绝经后。© 2020作者。由Wiley Periodicals, Inc.代表美国骨与矿物质研究学会出版。